Cardlytics (NASDAQ:CDLX) Upgraded at Craig Hallum

Cardlytics (NASDAQ:CDLX - Get Free Report) was upgraded by investment analysts at Craig Hallum from a "hold" rating to a "strong-buy" rating in a report released on Wednesday,Zacks.com reports.

CDLX has been the topic of a number of other reports. Evercore ISI initiated coverage on shares of Cardlytics in a research note on Friday, October 11th. They set an "in-line" rating and a $4.00 price objective on the stock. Northland Capmk cut shares of Cardlytics from a "strong-buy" rating to a "hold" rating in a research report on Friday, August 16th. Needham & Company LLC reissued a "hold" rating on shares of Cardlytics in a research report on Thursday. Lake Street Capital cut shares of Cardlytics from a "buy" rating to a "hold" rating and decreased their target price for the company from $18.00 to $5.00 in a research report on Thursday, August 8th. Finally, Bank of America cut shares of Cardlytics from a "neutral" rating to an "underperform" rating and decreased their target price for the company from $4.00 to $3.50 in a research report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Cardlytics has a consensus rating of "Hold" and a consensus target price of $6.92.

Cardlytics Stock Up 7.4 %

Shares of NASDAQ CDLX traded up $0.30 during midday trading on Wednesday, reaching $4.37. 1,752,054 shares of the company's stock traded hands, compared to its average volume of 1,242,283. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 1.01. The stock's 50 day simple moving average is $3.68 and its 200-day simple moving average is $6.76. Cardlytics has a one year low of $2.89 and a one year high of $20.52. The company has a market cap of $217.80 million, a price-to-earnings ratio of -1.21 and a beta of 1.61.

Cardlytics (NASDAQ:CDLX - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.21) by $0.12. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The firm had revenue of $69.64 million for the quarter, compared to the consensus estimate of $75.39 million. During the same period last year, the firm earned ($0.57) earnings per share. The company's quarterly revenue was down 9.2% on a year-over-year basis. On average, analysts predict that Cardlytics will post -1.72 EPS for the current fiscal year.

Insiders Place Their Bets

In other Cardlytics news, CEO Amit Gupta sold 22,607 shares of the firm's stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $3.85, for a total value of $87,036.95. Following the completion of the transaction, the chief executive officer now owns 178,519 shares of the company's stock, valued at approximately $687,298.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Cardlytics news, Director Scott A. Hill bought 40,000 shares of the firm's stock in a transaction that occurred on Monday, August 12th. The stock was bought at an average cost of $3.58 per share, for a total transaction of $143,200.00. Following the completion of the transaction, the director now directly owns 40,000 shares of the company's stock, valued at approximately $143,200. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Amit Gupta sold 22,607 shares of Cardlytics stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $3.85, for a total value of $87,036.95. Following the transaction, the chief executive officer now owns 178,519 shares of the company's stock, valued at approximately $687,298.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 43,573 shares of company stock valued at $151,612. Insiders own 4.40% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in Cardlytics by 2.7% in the first quarter. Vanguard Group Inc. now owns 2,211,595 shares of the company's stock valued at $32,046,000 after acquiring an additional 57,805 shares during the period. Marshall Wace LLP lifted its holdings in Cardlytics by 6.8% in the second quarter. Marshall Wace LLP now owns 814,281 shares of the company's stock valued at $6,685,000 after acquiring an additional 52,081 shares during the period. GSA Capital Partners LLP lifted its holdings in Cardlytics by 1,273.2% in the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company's stock valued at $1,223,000 after acquiring an additional 354,474 shares during the period. Renaissance Technologies LLC lifted its holdings in Cardlytics by 711.9% in the second quarter. Renaissance Technologies LLC now owns 351,035 shares of the company's stock valued at $2,882,000 after acquiring an additional 307,800 shares during the period. Finally, Kent Lake Capital LLC acquired a new position in Cardlytics in the first quarter valued at approximately $3,622,000. 68.10% of the stock is owned by institutional investors and hedge funds.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.